Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATRIX trial in acute coronary syndrome
2011-000430-11Phase 3Active
- Sponsor
- GISE
- Start
- Dec 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bivalirudin and heparin in acute coronary syndrome (ACS) (4 arms), sponsored by GISE. Started Dec 2011; status: active.
02
Drugs
bivalirudinheparin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2011-000430-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000430-11.